Wechselwirkungen · Stribild
Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 17
HOS-218484 · Präparat HOS-216207
The long-term effects of substantial increases in progestogen exposure are unknown. ANTIARRHYTHMICS Digoxin (0.5 mg single Digoxin: It is recommended that digoxin dose)/Cobicistat (150 mg multiple AUC: ↔ levels be monitored when digoxin doses) Cmax: ↑ 41% is combined with Stribild. Disopyramide Interaction not studied with any of the Caution is warranted and clinical Flecainide components of Stribild. monitoring is recommended upon Systemic lidocaine co-administration with Stribild. Mexiletine Concentrations of these antiarrhythmic Propafenone drugs may be increased when co-administered with cobicistat. ANTI-HYPERTENSIVES Metoprolol Interaction not studied with any of the Clinical monitoring is Timolol components of Stribild. recommended and a dose decrease may be necessary when these Concentrations of beta-blockers may be agents are co-administered with increased when co-administered with Stribild. cobicistat.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): propafenone (HOS-084530) flecainide (HOS-086203) lidocaine (HOS-108866) mexiletine (HOS-086341) digoxin (HOS-086172) disopyramide (HOS-085595) metoprolol (HOS-090094) timolol (HOS-090571)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-07-23T16:51:00Z · SHA-256 d3f228ded6370d77784fda3a53beaff9f1155c63df0f682c7673ee3cdc2ccdc5 · Passage d3886c870df4da2e078e9f682c4f721ccbf094bd86beefb10bd9ac23c078c177 · Zeichen 33792–35511 im Abschnitt